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ABSTRACT
Introduction Healthcare organisations recognise 
the moral imperative to address inequalities in health 
outcomes but often lack an understanding of which types 
of interventions are likely to reduce them. This realist 
review will examine the existing evidence on the types 
of interventions or aspects of routine care in general 
practice that are likely to decrease or increase health 
inequalities (ie, inequality- generating interventions) across 
cardiovascular disease, cancer, diabetes and chronic 
obstructive pulmonary disease.
Methods and analysis Our realist review will follow 
Pawson’s five iterative stages. We will start by developing 
an initial programme theory based on existing theories 
and discussions with stakeholders. To navigate the large 
volume of literature, we will access the primary studies 
through the identification of published systematic reviews 
of interventions delivered in general practice across 
the four key conditions. We will examine the primary 
studies included within each systematic review to identify 
those reporting on inequalities across PROGRESS- Plus 
categories. We will collect data on a range of clinical 
outcomes including prevention, diagnosis, follow- up and 
treatment. The data will be synthesised using a realist 
logic of analysis. The findings will be a description and 
explanation of the general practice interventions which are 
likely to increase or decrease inequalities across the major 
conditions.
Ethics and dissemination Ethics approval is not required 
because this study does not include any primary research. 
The findings will be integrated into a series of guiding 
principles and a toolkit for healthcare organisations to 
reduce health inequalities. Findings will be disseminated 
through peer- reviewed publications, conference 
presentations and user- friendly summaries.
PROSPERO registration number CRD42020217871.
INTRODUCTION
In the last decades, population health has 
significantly improved at least in high- income 
countries.1 However, it seems that this benefit 
is not proportionately distributed across 
groups within societies. Social inequalities in 
life expectancy, morbidity, mortality and their 
risk factors remain a persistent problem2 
which is expected to worsen during and after 
the COVID-19 pandemic.3 Recent reports 
show that chronic conditions such as cancer, 
heart disease, stroke and chronic obstructive 
pulmonary disease (COPD) are driving health 
inequalities in life expectancy.4 Specifically, in 
England, the gap in life expectancy between 
the least and most deprived areas is 9.4 years 
for men and 7.4 years for women,5 while the 
aforementioned conditions were responsible 
for two- thirds of premature mortality in the 
country in 2017.6 Although these inequalities 
are driven by wider determinants of health, 
such as employment, education and income, 
national healthcare systems have a vital role 
in defining their range and effects.7 In partic-
ular, general practice is key to reducing health 
inequalities. Previous research exploring 
cancer pathways found that inequalities tend 
to arise due to late presentation and diagnosis 
in general practice, rather than the diagnosis 
to treatment pathway in secondary care.8
However, understanding which are the 
most effective strategies for reducing health 
inequalities represents a challenge for 
national and international public health 
organisations. Besides routine healthcare that 
often fails to meet the needs of disadvantaged 
groups and increases health inequalities, 
there are also health interventions that may 
Strengths and limitations of this study
 ► A key strength of this study is that it will assimi-
late and synthesise a breadth of data across four 
conditions and different manifestations of health 
inequalities.
 ► A further strength is that the programme theory will 
be used to develop guidance and a toolkit for prac-
titioners and policy makers in collaboration with pa-
tient representatives at every state of the research.
 ► The two- stage approach to accessing the breadth of 
literature means that there is a possibility that some 
studies may be missed.
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decrease or increase inequalities. For example, workplace 
interventions to increase employee control or participa-
tion, fiscal policies, such as tobacco price increases and 
low agency interventions (ie, individuals only require a 
small amount of effort to benefit) are likely to reduce 
inequalities.9 However, media campaigns and work- 
based smoking bans tend to increase inequalities across 
socioeconomic groups and so do interventions which 
require high agency (ie, individuals require considerable 
personal resources to benefit). The latter are examples of 
what we call intervention- generated inequalities (IGIs)10 and 
refer to inequalities emerging from interventions which 
although they improve health overall, they increase 
inequalities by disproportionally benefitting advantaged 
groups or unintentionally negatively affecting disadvan-
taged groups.11–15 Moreover, the extent to which inter-
ventions increase or decrease inequalities may also vary 
over time. For example, research assessing inequalities in 
smoking found that population- based smoking interven-
tions may increase inequalities in the short- term as they 
benefit the most- affluent in society; however, over the 
long- term reduce inequalities as the benefit moves more 
towards lower socioeconomic groups.16
Healthcare services, which are often the first point 
of contact for vulnerable individuals, are estimated to 
contribute 15%–43% to health outcomes.7 In the UK, 
the National Health Service (NHS) acknowledges both 
a moral imperative to address systematic, unfair differ-
ences in health outcomes and a financial rationale with 
socioeconomic inequalities costing the NHS £4.8 billion/
year in hospitalisations alone.17 The NHS long- term plan 
promises a ‘more concerted and systematic approach to 
reducing health inequalities’ and about £1 billion addi-
tional funding for more deprived areas,18 with primary 
care being asked to develop specific plans to reduce 
health inequalities.19 However, in the context of complex 
and often contradictory evidence as described above, the 
NHS still lacks a thorough understanding of which types 
of interventions are likely to reduce inequalities20 and 
paradoxically which may inadvertently increase inequal-
ities.21 This realist review study will examine the existing 
evidence on interventions and aspects of routine care in 
general practice that are likely to increase or decrease 
health inequalities and will provide healthcare organisa-
tions with an evidence synthesis and guiding principles 
on what should be commissioned and how for the reduc-
tion of health inequalities.
Rationale
The last systematic review on health service interven-
tions to reduce inequalities was published 23 years ago 
based on articles published 25–35 years ago.22 The study 
focused on how to reduce inequalities but did not account 
for IGIs. The authors concluded that a multidisciplinary 
approach using a combination of strategies was more 
likely to reduce inequalities. However, the evidence base 
and the healthcare organisational landscape has changed 
substantially over the past 25 years.
An important development concerns the PROGRESS- 
Plus conceptual framework for different dimensions of 
inequalities.23 Proposed by the Campbell and Cochrane 
Collaborations, the framework encourages researchers 
to take a more systematic approach to equity by catego-
ries of disadvantaged groups—place of residence, race/
ethnicity/culture/language, occupation, gender/sex, 
religion, education, socioeconomic status, social capital, 
plus characteristics related to discrimination (eg, age 
and disability), features of relationships (eg, parents who 
smoke) and time- dependent relationships (eg, being a 
carer).
Attwood and colleagues14 reviewed primary- care- based 
physical activity interventions using the PROGRESS- 
Plus categories and identified 24 randomised controlled 
trial (RCT) studies in which differential effects of one 
or more PROGRESS- Plus criteria were reported, with 
gender (n=22) and age (n=16) being the most common, 
followed by race (n=4), education (n=3), social capital 
(n=3) and socioeconomic status (n=3). The authors 
found mixed effects for gender, and some evidence of 
improved physical activity for patients with higher base-
line social support. An additional review by Terens and 
colleagues24 on quality improvement strategies to reduce 
inequalities in diabetes care using the PROGRESS- Plus 
criteria showed that a quality improvement strategy 
improves care for older and less educated people, and 
African Americans. Moreover, Capewell and Graham25 
studied the role of cardiovascular disease prevention in 
the reduction of health inequalities. They compared the 
evidence about the effectiveness of a ‘high- risk approach’; 
where patients are categorised and treated according to 
risk, with ‘population- wide programmes’, like smoking 
bans and found that the former is more likely to increase 
inequalities compared with the latter. Similarly, Durand 
and colleagues15 reviewed the impact of shared decision- 
making across primary and secondary care on health 
inequalities and found that such interventions were likely 
to benefit disadvantaged groups and therefore reduce 
inequalities.
Although important, this evidence is disparate and 
limited as it emerges from reviews focused on RCTs. Broad-
ening the search to include non- RCT interventional or 
other studies will allow additional relevant interventions 
to emerge and be integrated into useable guidance. For 
example, a review of reviews shows that while the impact 
of social determinants of health interventions is generally 
unclear, there is evidence that housing and working envi-
ronment interventions reduce health inequalities.26 In 
this context, our study aims to provide healthcare systems 
and general practices with up- to- date, extended and inte-
grated evidence on interventions that decrease or increase 
health inequalities with details on who is most and least 
likely to benefit, in what circumstances, why and how, as 
well as specific guiding principles to commission general 
practice effectively to reduce inequalities. Additionally, 
the review will produce findings that can be applied 
internationally to guide general practice in a variety of 
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settings by uncovering specific contextual factors which 
are generally present in primary care settings and trigger 
mechanisms causing inequalities to increase or decrease.
Objectives
Our main objective is to explore what types of interven-
tions or aspects of routine care in general practice increase 
or decrease inequalities in outcomes of cardiovascular 
disease, cancer, diabetes or COPD, for whom, why, in what 
circumstances and how. Based on this evidence, we aim 
further to develop guidance and a toolkit for healthcare 
decision makers about how best to tackle health inequali-
ties through general practice services.
METHODS AND ANALYSIS
Existing research indicates that the interventions and 
routine care delivered in general practice are complex 
and context- specific, with a range of impacts on inequal-
ities in different settings. To account for this complexity, 
we will conduct a realist review, aiming to complete it by 
June 2022. In contrast to systematic reviews which seeks 
to draw conclusions on whether an intervention works or 
not, realist methods not only seek to understand which 
specific elements of interventions work, but also for which 
groups does it work, how does it work and why.10 27 Specif-
ically it draws on a context–mechanism–outcome (CMO) 
logic of analysis to develop context- dependent findings 
and outputs. The review will be conducted through the 
following steps.
Identifying existing theories
We will start by identifying existing theories that explain 
how, for whom, why and in what circumstances inter-
ventions delivered in general practice may increase 
or decrease health inequalities. To do this, we will first 
scope the literature on IGIs, starting with existing system-
atic reviews.9 10 14 27 The scoping of the literature will be 
exploratory based on informal methods like snow- balling 
and citation tracking28 to ensure that it will inform the 
search strategy without limiting its scope. Second, we will 
consult key content experts and third, we will refine our 
findings through iterative discussions within the project 
team to synthesise an initial programme theory. In line 
with the realist methodology, the initial programme 
theory as agreed among the different stakeholders will 
be broad enough to allow generalisability and guide our 
literature search.27
Literature search and screening
In our review, we will undertake an electronic search of 
MEDLINE, EMBASE, CINAHL, PsycINFO, the Web of 
Science and the Cochrane library to identify systematic 
reviews of interventions delivered in general practice 
across cardiovascular disease, cancer, diabetes or COPD. 
Our search strategy is available in online supplemental 
appendix 1. The identified titles and abstracts will be 
screened for eligibility by two reviewers and disagreements 
and unclear studies will be resolved through discussion. 
Any disagreements will be resolved through discussion. 
Our inclusion and exclusion criteria are found below.
Inclusion criteria
 ► Reviews that use a comprehensive search strategy and 
appropriate quality appraisal tool.
 ► Interventions which target cardiovascular disease, 
cancer, diabetes or COPD or their risk factors, namely, 
smoking, hypertension, diet, exercise and cholesterol.
 ► Interventions delivered in general practice.
 ► Clinical outcomes relating to the type of care (acute, 
chronic and preventative), function of care (diagnosis, 
screening and prevention, follow- up and continuity, 
treatment) and domain of care (effective, efficient, 
timely, patient- centred and safe).29
 ► Studies reporting on the differential effectiveness 
of care/intervention across groups or interventions 
targeted at disadvantaged groups.
 ► Studies undertaken in high- income countries, as 
defined by the Organisation for Economic Co- oper-
ation and Development (OECD), with no language 
restrictions.
Exclusion criteria
 ► Drug effectiveness or efficacy studies.
 ► Review articles superseded by more comprehensive 
reviews.
 ► Reviews on children, mental health or disease areas 
not listed above.
Next, the full text of the included primary studies in 
each of the reviews will be screened by two reviewers 
according to the following criteria:
Inclusion criteria
 ► Interventions which report clinical outcomes by soci-
oeconomic group, or other PROGRESS- Plus criteria, 
relating to the type of care (acute, chronic and 
preventative), function of care (diagnosis, screening 
and prevention, follow- up and continuity, and treat-
ment) and domain of care (effective, efficient, timely, 
patient- centred and safe).
 ► Interventional studies or interventions targeted at 
disadvantaged groups.
 ► General practice interventions targeting cardiovas-
cular disease, cancer, diabetes or COPD or their risk 
factors, namely, smoking, hypertension, diet, exercise 
and cholesterol.
 ► Clinical outcomes (eg, mortality and myocardial 
infarction) or clinical measures of risk factors (eg, 
change in Hb1Ac and blood pressure).
 ► Experimental study design.
 ► Studies undertaken in high- income countries, as 
defined by the OECD, with no language restrictions.
Exclusion criteria
 ► Drug effectiveness or efficacy studies.
More searches will be undertaken, if we require 
more data to develop and test certain subsections of 
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the programme theory. This will allow us to integrate 
useful evidence from non- RCT studies which are 
usually excluded from systematic reviews. For each 
additional search, the project team will set inclusion 
and exclusion criteria and follow the same screening 
processes as for the initial search. Where applicable, 
we will follow the search strategies developed by Booth 
and colleagues.30
Article selection
Documents will be selected based on relevance (ie, 
whether data can contribute to theory building and/
or testing) and rigour (ie, whether the methods used 
to generate the relevant data are credible and trust-
worthy). To illustrate how we will operationalise rigour, 
if relevant data have been generated using an RCT, 
then the trustworthiness of the data would be consid-
ered to be greater if the trial meets current quality 
criteria for rigour. Documents may still be included 
even if judged to be of limited rigour, as we will also be 
making an overall assessment of rigour at the level of 
the programme theory31 following the same decision- 
making process as outlined above.
Data extraction
The included papers will be uploaded to NVivo and 
sections of texts relating to contexts, mechanisms and 
their relationships to outcomes will be coded by AG. 
Codes will be inductive (ie, created to categorise data 
reported in included studies), deductive (ie, created 
in advance of data extraction as informed by the initial 
programme theory) and retroductive (ie, created based 
on an interpretation of data to infer what the hidden 
causal forces might be for outcomes). A random sample 
of 10% will be independently and additionally coded 
by JF and/or GW to improve consistency and quality. 
Key study characteristics, such as included patients, 
interventions and outcomes by socioeconomic group 
or other PROGRESS- Plus criteria, will be extracted 
using an Excel pro forma. Each new element of data 
will be used to refine the theory if appropriate, and as 
the theory is refined, included studies will be re- scru-
tinised for data relevant to the revised theory that may 
have been missed initially.
Data synthesis
Data will be analysed in light of the initial programme 
theory following current realist review quality and 
publication standards.32 We will use interpretive cross- 
case comparison to understand and explain how and 
why observed outcomes have occurred. As part of data 
synthesis, we will use a series of questions addressing 
the relevance and rigour of content, interpretation 
of meaning, as well as interpretations about CMO- 
configurations and the initial programme theory within 
and across documents. Theory driven data synthesis 
will allow us to move beyond the identification of 
intervention effects towards the causal mechanisms 
operating behind specific interventions and ultimately 
towards suggestions regarding the ways interventions 
can be more useful.
Developing guidance and a toolkit for practitioners and policy 
makers
The finalised programme theory, as it will emerge from 
the data synthesis, will be used to develop guidance and 
a toolkit for practitioners and policy makers. First, the 
research team will develop an initial guidance document 
and toolkit similar to previous work,33 which will then be 
refined during a 1- day deliberative workshop with the 
expert group, research team and key stakeholders (eg, 
NHS England, groups which represent disadvantaged 
communities). We are confident that the engagement 
of key stakeholders encouraged by realist methodology 
will benefit the outcomes and ensure their effectiveness 
within service delivery settings.
Patient and public involvement
Patient and public involvement (PPI) in the delivery of 
the research will be key. We will have three PPI repre-
sentatives as part of the Research Team. Our PPI team 
members will ensure that a patient and public voice is 
maintained throughout the research and will contribute 
to the design, interpretation of the findings and dissem-
ination activities. Furthermore, we will recruit a diverse 
range of individuals to attend expert group meetings and 
the Deliberative workshop.
Ethics and dissemination
Ethics approval is not required because this study does 
not include any primary research.
Our dissemination strategy will capitalise on the stake-
holder networks that we will establish during the research. 
We will consult with our expert panel to identify the main 
stakeholders for dissemination across different audiences 
and accordingly develop tailored materials for each audi-
ence, namely, primary care policy makers and commis-
sioners, general practitioners, members of the public, 
third- sector organisations and researchers.
To ensure that the findings have maximum impact we 
will produce a number of outputs tailored to the needs of 
the targeted audiences. We will produce a set of guiding 
principles aimed at all general practice services which will 
help decision makers and commissioners to understand 
the likely impact of their services on health inequalities 
and offer evidence- based suggestions for the tailoring or 
modification of services. The guidelines will further be 
integrated in a toolkit with greater detail and worked 
examples. The main target audience of this toolkit will 
be national, regional and local healthcare organisa-
tions. Additionally, the findings from the review will be 
submitted for publication to an open- access high- impact 
peer- reviewed journal for the academic audience. Our 
final project report will also be available on an open access 
basis to those interested in the detail of our methods and 
findings. Finally, to make relevant stakeholders aware 
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of the ‘headline’ findings of the realist review, we will 
produce summaries in a user- friendly and tailored format.
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